Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Clinical trial NCT07397338 · RECRUITING

Trial details

NCT number: NCT07397338
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Metastatic Solid Tumors Non-small Cell Lung Cancer (NSCLC)NSCLC Colorectal Cancer (CRC)CRC

Start date: 2026-01-30
Primary completion: 2029-05-01
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.